Shares of IDEXX Laboratories Inc. IDXX slipped 2.18% to $419.26 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.00% to ...

IDEXX Laboratories Inc. closed $160.77 short of its 52-week high ($583.39), which the company achieved on March 1st.

IDEXX Laboratories, Inc. (IDXX), valued at a market cap of almost $35 billion, develops, manufactures, and distributes ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3 ...

ST Germain D J Co. Inc. grew its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 517.2% in the 4th quarter, ...

Headquartered in Westbrook, ME, IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry ...

Signal Advisors Wealth LLC raised its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 25.7% in the fourth ...

While IDEXX Laboratories, Inc. (NASDAQ:IDXX) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 21% in the last quarter.

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks An announcement from Idexx Laboratories ( (IDXX)) is now available. IDEXX Laboratories has approved a ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neumora Therapeutics, Inc. (NMRA – Research Report) and ...

IDEXX Laboratories, Inc. (IDXX), valued at a market cap of almost $35 billion, develops, manufactures, and distributes products mainly for the companion animal veterinary, livestock and poultry ...